4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000062
Chief Medical Officer sold 892 shares at an average $13.48 ($12,022)
- Chief Medical Officer gave up 401 shares (to pay taxes)
- Chief Medical Officer acquired 14,200 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KREHER NERISSA Chief Medical Officer | 2023-09-01 | Grant or award 10b5-1 | +14,200 | 41,330 | D: show line 1 in the form | ||
| KREHER NERISSA Chief Medical Officer | 2023-09-05 | Shares withheld for taxes 10b5-1 | −401 | $14.46 | $5,799 | 40,929 | D: show line 2 in the form |
| KREHER NERISSA Chief Medical Officer | 2023-09-06 | Sale 10b5-1 | −871 | $13.46 | $11,728 | 40,058 | D: show line 3 in the form |
| KREHER NERISSA Chief Medical Officer | 2023-09-06 | Sale 10b5-1 | −21 | $14.00 | $294 | 40,037 | D: show line 4 in the form |
| Open-market sales · 892 sh · avg $13.48 · $12,022 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KREHER NERISSA Chief Medical Officer | 2023-09-01 | Grant or award · Stock Option (Right to Buy) 10b5-1 | +21,500 | 21,500 | D: show line 5 in the form |
Loading xslF345X05/wf-form4_169403451511634.xml…